SOAGY — Sartorius AG/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 1715801 ·
Last close
$57.52
Market Cap
$10.01B
52W High
$58.72
52W Low
$48.10
ADV30
5,460
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 911,800,000 | 433,100,000 | 164,100,000 | 65,900,000 | 9,601,500,000 | 291,000,000 | 5,604,000,000 |
| Mar 2026 | 899,100,000 | 414,500,000 | 153,800,000 | 56,200,000 | 9,872,100,000 | 573,800,000 | 5,981,400,000 |
| Dec 2025 | 927,600,000 | 396,200,000 | 170,200,000 | 93,200,000 | 9,717,200,000 | 541,400,000 | 5,849,900,000 |
| Jun 2025 | 884,300,000 | 416,200,000 | 131,900,000 | 32,500,000 | 10,027,200,000 | 819,000,000 | 6,232,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$840,600,000
Investing CF
$-381,500,000
Financing CF
$-577,000,000
CapEx
$-383,400,000
Dividends Paid
$-50,900,000
Buybacks
—
EPS Diluted TTM
$0.59
As of
2026-08-09
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,581,700,096
EBITDA
$938,499,968
Free Cash Flow
$324,687,488
Enterprise Value
$24,691,359,744
Total Cash
$291,300,000
Total Debt
$4,052,100,096
Shares Out
174,068,105
Trailing EPS
$0.66
Book Value
$45.81
ROE
7.2%
ROA
3.9%
Div Yield
0.29%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,538,100,000 | 569,200,000 | 154,900,000 | 9,717,200,000 | 5,849,900,000 | — | 837,000,000 |
| Dec 2024 | 3,380,700,000 | 437,200,000 | 84,000,000 | 10,103,000,000 | 6,205,200,000 | — | 976,200,000 |
| Dec 2023 | 3,395,700,000 | 543,900,000 | 205,600,000 | 9,745,500,000 | 6,987,500,000 | — | 853,600,000 |
| Dec 2022 | 4,174,700,000 | 1,139,300,000 | 678,100,000 | 6,977,700,000 | 4,318,800,000 | — | 734,200,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PSO | PEARSON PLC | $10.01B | $16.64 | — |
| KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | $9.95B | $53.07 | — |
| CGNX | COGNEX CORP | $9.85B | $58.54 | — |
| FCFS | FirstCash Holdings, Inc. | $10.25B | $236.43 | — |
| AVTR | Avantor, Inc. | $9.64B | $14.26 | — |
News headlines (Yahoo Finance, 1h cache)
Sartorius Opens New Competence Center for cell and Gene Therapy Components in Freiburg, Germany
2026-05-21 11:25 · Yahoo
Assessing Sartorius (XTRA:SRT3) Valuation After Share Price Weakness And A High P/E Multiple
2026-05-15 08:13 · Yahoo
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More
2026-02-19 12:22 · Yahoo
Sartorius Releases Annual Report for 2025
2026-02-16 23:00 · Yahoo
[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Gro
2026-02-10 21:30 · Yahoo
Sartorius Aktiengesellschaft Q4 Earnings Call Highlights
2026-02-03 17:38 · Yahoo
Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA
2025-12-01 11:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.